Skip to main content
SpringerLink
Log in

Human papillomavirus vaccine recombinant quadrivalent

First report of lymphadenopathy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Studdiford J, Lamb K, Horvath K, Altshuler M, Stonehouse A.Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination. Pharmacotherapy 28: 1194-1197, No. 9, Sep 2008 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Human papillomavirus vaccine recombinant quadrivalent. React. Wkly. 1223, 15 (2008). https://doi.org/10.2165/00128415-200812230-00048

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812230-00048

Keywords

Search

Navigation